Genomic studies are celebrated for the transformative impact on human health and wellbeing, with recent examples during the pandemic demonstrating the value of this area of science. It is widely known, however, that the limitation in diverse genomic data and research results in inequalities in access to genomic and personalised medicine, largely affecting communities that are traditionally underserved.
Watch this summary of Lifebit's webinar on 6 July 2023 for the highlights from pioneers in genomic data research and technology, including Victor Angel-Mosti, CEO and Founder of Omica.bio in Mexico, Prof Lygia da Veiga Pereira, gen-t Science in Brazil, Dr Matt Silver, Lead Genomic Data Scientist ‐ Diversity at Genomics England, and Dr Maria Dunford, CEO of Lifebit.
